Universal Ibogaine Announces Private Placement Financing and the Results of the Annual Meeting of Shareholders
Calgary, AB – TheNewswire - April 22, 2024 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it intends to undertake a non-brokered private placement offering of up to 23,333,333 common shares at a price of $0.015 per share, for proceeds of up to $350,000 [...]